Article Details

Novartis to Acquire Tourmaline Bio for $1.4 Billion - Contract Pharma

Retrieved on: 2025-09-09 18:50:47

Tags for this article:

Click the tags to see associated articles and topics

Novartis to Acquire Tourmaline Bio for $1.4 Billion - Contract Pharma. View article details on hiswai:

Excerpt

Novartis has agreed to acquire Tourmaline Bio Inc., a clinical-stage biopharmaceutical company focused on developing pacibekitug.

Article found on: www.contractpharma.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo